What is the average price target for NUCOR CORP (NUE) stock?
22 analysts have analysed NUE and the average price target is 189.64 USD. This implies a price decrease of -11.49% is expected in the next year compared to the current price of 214.26.
NYSE:NUE • US6703461052
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NUCOR CORP (NUE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-04-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-03-26 | UBS | Upgrade | Neutral -> Buy |
| 2026-03-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-03-16 | UBS | Maintains | Neutral -> Neutral |
| 2026-03-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-28 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-09 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-12-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-10 | Jefferies | Maintains | Buy -> Buy |
| 2025-12-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-14 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-10-30 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-29 | UBS | Maintains | Buy -> Buy |
| 2025-10-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-28 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-18 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-15 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-15 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-14 | Wells Fargo | Initiate | Equal-Weight |
| 2025-07-31 | Jefferies | Upgrade | Hold -> Buy |
| 2025-07-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.714B -16.38% | 30.734B -11.46% | 32.494B 5.73% | 36.415B 12.07% | 37.924B 4.14% | 38.804B 2.32% | 38.937B 0.34% | |
| EBITDA YoY % growth | 7.399B -36.04% | 4.335B -41.41% | 4.139B -4.52% | 5.731B 38.46% | 6.157B 7.43% | 6.184B 0.44% | 6.23B 0.74% | |
| EBIT YoY % growth | 6.23B -40.70% | 2.979B -52.19% | 2.659B -10.74% | 4.115B 54.76% | 4.463B 8.46% | 4.662B 4.46% | 4.75B 1.89% | |
| Operating Margin | 17.95% | 9.69% | 8.18% | 11.30% | 11.77% | 12.01% | 12.20% | |
| EPS YoY % growth | 17.99 -37.38% | 8.85 -50.81% | 7.78 -12.09% | 12.54 61.21% | 13.88 10.65% | 14.90 7.34% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.85 270.48% | 3.62 36.53% | 3.51 33.50% | 2.73 57.92% | 3.41 19.67% | 3.53 -2.46% | 3.61 2.70% | 3.14 14.97% | 3.15 -7.69% | 3.56 0.74% | 3.51 -2.52% | 3.43 9.32% |
| Revenue Q2Q % growth | 8.973B 14.60% | 9.574B 13.22% | 9.416B 10.50% | 8.657B 12.62% | 9.534B 6.25% | 9.684B 1.15% | 9.689B 2.90% | 9.124B 5.39% | 9.803B 2.82% | 10.037B 3.65% | 9.899B 2.17% | 9.412B 3.16% |
| EBITDA Q2Q % growth | 1.347B 94.65% | 1.573B -4.84% | 1.532B -22.98% | 1.275B -36.50% | 1.497B 11.14% | 1.506B -4.26% | 1.518B -0.91% | 1.429B 12.08% | 1.445B -3.47% | 1.548B 2.79% | 1.525B 0.46% | 1.481B 3.64% |
| EBIT Q2Q % growth | 952.28M 193.91% | 1.198B 30.36% | 1.135B 27.82% | 885.71M 67.75% | 1.04B 9.21% | 1.035B -13.61% | 1.059B -6.70% | 975.81M 10.17% | 990.34M -4.78% | 1.09B 5.31% | 1.068B 0.85% | 1.027B 5.25% |
All data in USD
22 analysts have analysed NUE and the average price target is 189.64 USD. This implies a price decrease of -11.49% is expected in the next year compared to the current price of 214.26.
NUCOR CORP (NUE) will report earnings on 2026-04-27, after the market close.
The consensus EPS estimate for the next earnings of NUCOR CORP (NUE) is 2.85 USD and the consensus revenue estimate is 8.97B USD.
The number of analysts covering NUCOR CORP (NUE) is 22.